116 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34820556 | Near-infrared light triggered multi-hit therapeutic nanosystem for tumor specific photothermal effect amplified signal pathway regulation and ferroptosis. | 2022 Mar | 4 |
2 | 35327426 | Different HSP90 Inhibitors Exert Divergent Effect on Myxoid Liposarcoma In Vitro and In Vivo. | 2022 Mar 7 | 1 |
3 | 33416122 | Heat shock protein 90 as a molecular target for therapy in oral squamous cell carcinoma: Inhibitory effects of 17‑DMAG and ganetespib on tumor cells. | 2021 Feb | 1 |
4 | 34055735 | Development and Characterization of PLGA Nanoparticles Containing 17-DMAG, an Hsp90 Inhibitor. | 2021 | 7 |
5 | 34200311 | Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin. | 2021 Jun 7 | 2 |
6 | 34956178 | A Novel Role for the Regulatory Nod-Like Receptor NLRP12 in Anti-Dengue Virus Response. | 2021 | 1 |
7 | 31726100 | Destabilization of ROR1 enhances activity of Ibrutinib against chronic lymphocytic leukemia in vivo. | 2020 Jan | 1 |
8 | 32151689 | 17-DMAG disrupted the autophagy flux leading to the apoptosis of acute lymphoblastic leukemia cells by inducing heat shock cognate protein 70. | 2020 May 15 | 1 |
9 | 32497199 | Heat shock protein 90 inhibitors suppress pyroptosis in THP-1 cells. | 2020 Oct 30 | 1 |
10 | 32608202 | Synergistic Antitumor Effects of Combined Treatment with HSP90 Inhibitor and PI3K/mTOR Dual Inhibitor in Cisplatin-Resistant Human Bladder Cancer Cells. | 2020 Jul | 1 |
11 | 30788006 | HSP90 inhibitor 17-DMAG effectively alleviated the progress of thoracic aortic dissection by suppressing smooth muscle cell phenotypic switch. | 2019 | 2 |
12 | 31611575 | A docking-based structural analysis of geldanamycin-derived inhibitor binding to human or Leishmania Hsp90. | 2019 Oct 14 | 2 |
13 | 29433909 | Heat shock protein 90 inhibitor enhances apoptosis by inhibiting the AKT pathway in thermal-stimulated SK-MEL-2 human melanoma cell line. | 2018 Jun | 1 |
14 | 29602128 | Targeted cancer therapy through 17-DMAG as an Hsp90 inhibitor: Overview and current state of the art. | 2018 Jun | 3 |
15 | 30021337 | 17-DMAG-loaded nanofibrous scaffold for effective growth inhibition of lung cancer cells through targeting HSP90 gene expression. | 2018 Sep | 5 |
16 | 30453475 | Targeting the MYC Oncogene in Burkitt Lymphoma through HSP90 Inhibition. | 2018 Nov 16 | 2 |
17 | 27600766 | Evaluation of the radiosensitizing potency of chemotherapeutic agents in prostate cancer cells. | 2017 Feb | 1 |
18 | 27887849 | Inhibition of heat shock protein (Hsp) 90 potentiates the antiproliferative and pro-apoptotic effects of 2-(4'fluoro-phenylamino)-4H-1,3-thiazine[6,5-b]indole in A2780cis cells. | 2017 Jan | 2 |
19 | 28255900 | Re-examining HSPC1 inhibitors. | 2017 Mar | 1 |
20 | 28529458 | Targeting HSP90-HDAC6 Regulating Network Implicates Precision Treatment of Breast Cancer. | 2017 | 1 |
21 | 28779264 | Hyponatremia and V2 vasopressin receptor upregulation: a result of HSP90 inhibition. | 2017 Oct | 1 |
22 | 28823258 | [Proliferation and Apoptosis of Leukemia Cell Line K562 Treated with HSP90 Inhibitor 17-DMAG]. | 2017 Aug | 3 |
23 | 28823260 | [Effect of Heat Shock Protein 90 Inhibitor 17-DMAG on Proliferation and Apoptosis of Acute Lymphocytic Leukemia Cell Line Jurkat]. | 2017 Aug | 2 |
24 | 28871086 | Identification of HSP90 inhibitors as a novel class of senolytics. | 2017 Sep 4 | 1 |
25 | 28914785 | Hsp90α Mediates BMI1 Expression in Breast Cancer Stem/Progenitor Cells through Facilitating Nuclear Translocation of c-Myc and EZH2. | 2017 Sep 15 | 2 |
26 | 28915605 | HSP90 inhibitor 17-DMAG exerts anticancer effects against gastric cancer cells principally by altering oxidant-antioxidant balance. | 2017 Aug 22 | 2 |
27 | 26379118 | Organ-specific efficacy of HSP90 inhibitor in multiple-organ metastasis model of chemorefractory small cell lung cancer. | 2016 Mar 1 | 1 |
28 | 26662567 | 17-DMAG induces heat shock protein 90 functional impairment in human bladder cancer cells: knocking down the hallmark traits of malignancy. | 2016 May | 6 |
29 | 26764527 | A phase I trial of the intravenous Hsp90 inhibitor alvespimycin (17-DMAG) in patients with relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma. | 2016 Sep | 2 |
30 | 26786409 | Hypoxia attenuates Hsp90 inhibitor 17-DMAG-induced cyclin B1 accumulation in hepatocellular carcinoma cells. | 2016 Mar | 1 |
31 | 26872308 | Acquired resistance to HSP90 inhibitor 17-AAG and increased metastatic potential are associated with MUC1 expression in colon carcinoma cells. | 2016 Jun | 1 |
32 | 27013225 | Current Understanding of HSP90 as a Novel Therapeutic Target: An Emerging Approach for the Treatment of Cancer. | 2016 | 2 |
33 | 27107422 | Hsp90 inhibition increases SOCS3 transcript and regulates migration and cell death in chronic lymphocytic leukemia. | 2016 May 10 | 1 |
34 | 27170753 | HSP90 Chaperoning in Addition to Phosphoprotein Required for Folding but Not for Supporting Enzymatic Activities of Measles and Nipah Virus L Polymerases. | 2016 Aug 1 | 2 |
35 | 27268613 | Targeting HSP90 Gene Expression with 17-DMAG Nanoparticles in Breast Cancer Cells. | 2016 | 2 |
36 | 27489107 | Regulation of Ubiquitin-like with Plant Homeodomain and RING Finger Domain 1 (UHRF1) Protein Stability by Heat Shock Protein 90 Chaperone Machinery. | 2016 Sep 16 | 1 |
37 | 27563925 | Reduced Contractility and Motility of Prostatic Cancer-Associated Fibroblasts after Inhibition of Heat Shock Protein 90. | 2016 Aug 24 | 3 |
38 | 25739426 | Heat shock protein 90 is required for ex vivo neutrophil-driven autoantibody-induced tissue damage in experimental epidermolysis bullosa acquisita. | 2015 Jun | 1 |
39 | 25855731 | Molecular chaperone Hsp90 is a therapeutic target for noroviruses. | 2015 Jun | 6 |
40 | 25920748 | The HSP90 inhibitor alvespimycin enhances the potency of telomerase inhibition by imetelstat in human osteosarcoma. | 2015 | 2 |
41 | 25940182 | [Co-inhibition effect of 17-DMAG and oxaliplatin on proliferation and invasion of colorectal cancer cells]. | 2015 Apr | 2 |
42 | 26219569 | P-glycoprotein confers acquired resistance to 17-DMAG in lung cancers with an ALK rearrangement. | 2015 Jul 29 | 2 |
43 | 24293393 | The growth inhibitory effect of 17-DMAG on ALK and MYCN double-positive neuroblastoma cell line. | 2014 Apr | 1 |
44 | 24418474 | Enhanced cytotoxic effect of radiation and temozolomide in malignant glioma cells: targeting PI3K-AKT-mTOR signaling, HSP90 and histone deacetylases. | 2014 Jan 13 | 1 |
45 | 24671949 | In vivo fluorescence lifetime imaging for monitoring the efficacy of the cancer treatment. | 2014 Jul 1 | 1 |
46 | 24694060 | Inhibitory effects of heat shock protein 90 blockade on proinflammatory human Th1 and Th17 cell subpopulations. | 2014 Apr 2 | 1 |
47 | 24784839 | FGFR3 translocations in bladder cancer: differential sensitivity to HSP90 inhibition based on drug metabolism. | 2014 Jul | 1 |
48 | 24796797 | Hsp90 blockade modulates bullous pemphigoid IgG-induced IL-8 production by keratinocytes. | 2014 Nov | 1 |
49 | 24961936 | Immunomodulatory effects of heat shock protein 90 inhibition on humoral immune responses. | 2014 Aug | 1 |
50 | 25153785 | Combined inhibition of Hsp90 and the proteasome affects NSCLC proteostasis and attenuates cell migration. | 2014 Oct | 1 |